prednisone has been researched along with incb-018424 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Diepstra, A; Huls, G; Kibbelaar, R; Nijland, M; Seitz, A; van den Berg, A; van Meerten, T; Visser, L | 1 |
| Holler, E; Jagasia, M; Jenq, R; Malard, F; Martin, P; Mohty, M; Socié, G; Zeiser, R | 1 |
| Gauthier, M; Laurent, C; Mouchel, PL; Syrykh, C; Tavitian, S | 1 |
| Chen, J; Gale, RP; Li, B; Pan, L; Qin, T; Qu, S; Wu, J; Xiao, Z; Xu, Z; Yan, X; Zhang, P; Zhang, Y | 1 |
| Culos, S; Deotare, U; Elemary, M; Hamad, N; Kelly, K; Kim, DDH; Kumar, R; Law, A; Linn, SM; Novitzky-Basso, I; Tan, SK; White, J; Xenocostas, A | 1 |
| Chen, C; Gan, YZ; Jia, Y; Jin, YB; Li, C; Li, GM | 1 |
| Duployez, N; Faguer, S; Groh, M; Hunault-Berger, M; Kahn, JE; Lefevre, G; Paul, C; Renaudineau, Y; Vergez, F | 1 |
| Culos, S; Deotare, U; Elemary, M; Hamad, N; Kelly, K; Kim, DDH; Kumar, R; Law, A; Linn, SM; Mattsson, J; Novitzky-Basso, I; Tan, S; White, J; Xenocostas, A | 1 |
2 review(s) available for prednisone and incb-018424
| Article | Year |
|---|---|
Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Child; Disease Progression; Drug Resistance; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Nitriles; Prednisone; Pyrazoles; Pyrimidines; Salvage Therapy; Therapies, Investigational; Treatment Failure; Young Adult | 2020 |
[Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review].
Topics: Aged; Anti-Bacterial Agents; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Exanthema; Female; Ferritins; Fibrinogen; Glucocorticoids; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Panniculitis; Prednisone | 2022 |
1 trial(s) available for prednisone and incb-018424
| Article | Year |
|---|---|
A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure.
Topics: Bronchiolitis Obliterans Syndrome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Prednisone; Retrospective Studies; Salvage Therapy | 2023 |
6 other study(ies) available for prednisone and incb-018424
| Article | Year |
|---|---|
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melphalan; Nitriles; Nitrogen Mustard Compounds; Prednisone; Primary Myelofibrosis; Pyrazines; Pyrazoles; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2014 |
Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Janus Kinase 1; Janus Kinase 2; Lymphoma, B-Cell; Mediastinal Neoplasms; Molecular Targeted Therapy; Neoplasm Proteins; Nitriles; Prednisone; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Vincristine | 2018 |
First case of classical Hodgkin-like EBV-positive lymphoproliferative disorder under ruxolitinib therapy.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Deoxycytidine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Humans; Immunocompromised Host; Lymph Nodes; Lymphoproliferative Disorders; Male; Middle Aged; Nitriles; PAX5 Transcription Factor; Prednisone; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reed-Sternberg Cells; RNA, Viral; Thrombocythemia, Essential; Vinblastine | 2021 |
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Topics: Anemia; Danazol; Hemoglobins; Humans; Myeloproliferative Disorders; Nitriles; Pilot Projects; Prednisone; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Thalidomide; Thrombocytopenia; Transaminases; Treatment Outcome | 2022 |
JAK inhibition for CD3
Topics: CD3 Complex; CD4-Positive T-Lymphocytes; Humans; Hypereosinophilic Syndrome; Prednisone; Prospective Studies | 2023 |
Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure.
Topics: Bronchiolitis Obliterans Syndrome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Prednisone; Propensity Score; Retrospective Studies | 2023 |